S
Soleno Therapeutics D
D
SLNO
68.265
USD
-1.25
(-1.79%)
مفتوح الان
حجم التداول
2,826
الربح لكل سهم
-1
العائد الربحي
-
P/E
-16
حجم السوق
3,646,810,518
الأخبار المقالات
العنوان: Soleno Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.